RecruitingPhase 4NCT04205916

A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery

A Prospective Trial Evaluating a Intracanalicular Insert Delivery System Compared to Traditional Topical Drops in Controlling Post-operative Pain and inFlammation in Subjects Undergoing Sequential Bilateral Cataract Surgery

Sponsor

Ophthalmic Consultants of Long Island

Enrollment

50 participants

Start Date

Nov 4, 2019

Study Type

INTERVENTIONAL

Conditions

Patient Preference

Summary

To evaluate the safety and ocular efficacy of Dextenza in combination with an intracameral antibiotic and NSAID in controlling post-operative ocular pain and inflammation compared to standard of care topical therapy in patients undergoing bilateral cataract surgery.

Eligibility

Min Age: 22 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Dexamethasone and Standard of care surgery for people with patient preference. The study is currently recruiting participants at 1 location. People eligible for this study include aged 22 Years to 100 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.